1. Home
  2. POAS vs TXMD Comparison

POAS vs TXMD Comparison

Compare POAS & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

POAS

Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

N/A

Current Price

$2.49

Market Cap

22.9M

Sector

Industrials

ML Signal

N/A

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.04

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POAS
TXMD
Founded
2017
2008
Country
Singapore
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
24.3M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
POAS
TXMD
Price
$2.49
$2.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
19.3K
Earning Date
05-21-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
73.68
EPS
N/A
0.01
Revenue
N/A
$1,761,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$202.00
Revenue Growth
N/A
35.25
52 Week Low
$0.53
$0.98
52 Week High
$7.40
$2.95

Technical Indicators

Market Signals
Indicator
POAS
TXMD
Relative Strength Index (RSI) 61.82 48.17
Support Level $1.40 $1.93
Resistance Level $3.84 $2.05
Average True Range (ATR) 0.15 0.10
MACD 0.02 0.00
Stochastic Oscillator 82.45 44.59

Price Performance

Historical Comparison
POAS
TXMD

About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: